Corporacion Ecuatoriana de Biotecnologia Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2000
NCT00228254
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now